Clinical trials · Detroit, MI
Left Ventricular Systolic Dysfunction clinical trials in Detroit
We’re tracking 3 recruiting left ventricular systolic dysfunction studies with a site in or near Detroit — including Phase 2/Phase 3 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Detroit
- NCT07192952RecruitingPhase 3
Long-term safety of finerenone in children and young adults with heart failure
This study tests the long-term safety of the drug finerenone when taken alongside standard heart failure treatments in children and young adults with weakened heart pumping function (left ventricular systolic dysfunction). It includes both children already in a related study and new infants under 6 months old.
Ann Arbor, MichiganAges Up to 18 years - NCT07188805RecruitingPhase 3
Finerenone for children with heart failure
This study tests a new medicine called finerenone (a pill) to see if it helps children with heart failure who have a weak pumping heart. It compares finerenone to a placebo (a pill with no medicine) while both groups continue their usual heart treatments.
Ann Arbor, MichiganAges 6 months–17 years - NCT05714085RecruitingPhase 2/Phase 3
Vericiguat study for children with heart failure
This trial tests whether vericiguat helps children with chronic heart failure caused by weaker left heart pumping. It also checks safety and how the medicine behaves in the body (dose and processing).
Ann Arbor, MichiganAges 4 weeks–17 years
Hear when a new Left Ventricular Systolic Dysfunction trial opens near Detroit, MI
We’ll email you when one opens near Detroit, MI — at most once a week, no account needed, unsubscribe anytime.
Left Ventricular Systolic Dysfunction trials in other cities
Where these studies are running near Detroit
Institutions with a site for the recruiting left ventricular systolic dysfunction studies listed above.
- University of Michigan · 3 studies
What taking part in a left ventricular systolic dysfunction study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting left ventricular systolic dysfunction studies in Michigan.
Common questions
- Are there left ventricular systolic dysfunction clinical trials near Detroit?
- Yes. We're currently tracking 3 recruiting left ventricular systolic dysfunction studies with a site near Detroit, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a left ventricular systolic dysfunction study near Detroit?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Detroit to take part?
- Not necessarily. These studies have a site near Detroit, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a left ventricular systolic dysfunction trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New left ventricular systolic dysfunction studies open near Detroit regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.